ATI RN
Free Pediatric CCRN Practice Questions Questions
Question 1 of 5
Joel has some internal bleeding. At which of the following sites is the most common for the child with hemophilia to bleed?
Correct Answer: C
Rationale: In children with hemophilia, the most common site for bleeding is at the ends of the long bones, such as the joints (especially the knees, elbows, and ankles). This is due to the joints being more prone to injury and stress during physical activities. As a result, spontaneous bleeding or bleeding following minor trauma can occur at these sites. Internal bleeding in the cerebrum or intestines is less common in children with hemophilia compared to bleeding in the joints.
Question 2 of 5
For a client with low blood volume, what are the implications of decreasing blood pressure and a rapid heart rate?
Correct Answer: D
Rationale: In a client with low blood volume, a decrease in blood pressure and a rapid heart rate can indicate hypovolemia, which is a condition characterized by a decreased volume of circulating blood. This can lead to inadequate perfusion of vital organs, including the kidneys (choice C), as well as other tissues throughout the body. If left unaddressed, severe hypovolemia can progress to shock, a critical condition where there is inadequate blood flow to meet the body's metabolic demands. This can result in organ dysfunction and potentially life-threatening complications. Therefore, the implications of decreasing blood pressure and a rapid heart rate in a client with low blood volume are indicative of hypovolemia and the potential development of shock.
Question 3 of 5
In assessing clients for pernicious anemia, the nurse should be alert for which of the following risk factors?
Correct Answer: C
Rationale: Pernicious anemia is primarily caused by the body's inability to absorb vitamin B12 due to a lack of intrinsic factor produced by the stomach. However, chronic blood loss can also lead to anemia by depleting the body's iron stores necessary for the production of healthy red blood cells. Acute blood loss can quickly lower the hemoglobin levels in the blood, while chronic blood loss can lead to iron-deficiency anemia over time. Therefore, in assessing clients for pernicious anemia, the nurse should be alert for the risk factor of acute or chronic blood loss as a potential cause of anemia.
Question 4 of 5
A client who reports increasing difficulty swallowing, weight loss, and fatigue is diagnosed with esophageal cancer. Because this client has difficulty swallowing, the nurse should assign highest priority to:
Correct Answer: B
Rationale: In a client with esophageal cancer who is experiencing difficulty swallowing, maintaining a patent airway is the highest priority. The client is at risk for aspiration due to the compromised ability to swallow, which could lead to respiratory distress, choking, or aspiration pneumonia. Adequate oxygenation is essential for the client's survival and must be addressed as the priority issue. While coping with body image, preventing injury, and ensuring nutrition are important aspects of care, they are secondary to ensuring the client's airway remains open and clear to prevent respiratory complications.
Question 5 of 5
A client metastatic ovarian cancer is prescribed cisplatin (Platinol). Before administering the first dose, the nurse reviews the client's medication history for drugs that may interact with cisplatin. Which drug may cause significant interactions when given concomitantly with cisplatin?
Correct Answer: D
Rationale: Amino glycosides, such as gentamicin or amikacin, can interact significantly with cisplatin, leading to increased risk of kidney damage or hearing loss. Both amino glycosides and cisplatin are known to have nephrotoxic and ototoxic effects independently. When combined, the risk of these side effects is potentiated, making it important to monitor renal function and hearing closely when these drugs are co-administered. Therefore, it is crucial to avoid the concomitant use of amino glycosides with cisplatin in order to prevent harmful drug interactions and reduce the risk of adverse effects in the client with metastatic ovarian cancer.